Reducing Hereditary Cancer Act of 2023

This bill requires Medicare to cover genetic testing for inherited cancer risks (like BRCA mutations) for beneficiaries with a personal or family history of hereditary cancer, as defined by current medical guidelines. It also mandates coverage for risk-reducing surgeries (such as mastectomies or hysterectomies) when recommended by those guidelines, and increases the frequency of evidence-based screenings (like annual mammograms or colonoscopies) for individuals with confirmed genetic mutations. The policy change applies to Medicare beneficiaries diagnosed with hereditary cancer gene mutations or at high risk due to family history, aligning coverage with established oncology standards. It does not alter existing Medicare rules but expands coverage for specific preventive services under defined clinical protocols.